MS Views and News

MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information

Wednesday, April 13, 2011

MS in the News: ORAL medications, Keeping Cool, Pharma Resources & more...


If you are having trouble viewing this message, please Click Here

 Today is: April 14, 2011

THIS e-Newsletter is 
reaching people in (83) Countries 

Tell us what you think... 
 TOPICS this week include:
CCSVI Update, Cooling Vests, 
Information on Hot Weather,
This week's podcast,
Pharmaceutical Resources,
Social Media, Learning Videos
and more....  

"Providing You with
'MS Views and News', 
IS What We Do" _______________________________


 WE are a NOT for Profit

MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law.

  •        Every Dollar Counts

  •          Please click here 

  •   All Contibutions are Tax Deductible 

  •  xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx  
     UPDATED News and Information

    Biogen Idec’s oral multiple sclerosis candidate, BG-12 (dimethyl fumarate), met its primary endpoint in the first of two Phase III pivotal trials in patients with relapsing-remitting disease
    Apr 13, 2011

    Multiple Sclerosis Cooling Program
    Apr 13, 2011

    New Copaxone® data reported from AAN demonstrate clinical benefits of switching MS patients to Copaxone®.
    Apr 13, 2011

    Potential New MS PIll: Experimental medication slowed the rate of brain atrophy and disease progression and relapse, study found
    Apr 13, 2011

    Apr 13, 2011

    Biogen Idec's Ongoing Dedication To People Living With MS
    Apr 12, 2011

    Oral Laquinimod For MS Treatment Significantly Reduced Disease Activity And Disability Progression While Providing Good Safety And Tolerability
    Apr 12, 2011

    Mayo Clinic Finds Tool To Predict Disability Timeline For Progressive MS Patients
    Apr 12, 2011

    "Laughter is the Best Medicine" - a Two Night performance on Long Island (NY) to benefit MS education
    Apr 12, 2011

    Biogen Oral MS Pill Meets Goals of Study
    Apr 11, 2011

    Media Release: Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of disease severity
    Apr 11, 2011

    Laquinimod, Alemtuzumab, CCSVI, and much more, to be discussed at the AAN meeting in Hawaii, April 9th thru 16th
    Apr 08, 2011

    Tysabri Label Modified to Include More Brain Infection Data
    Apr 08, 2011

    CCSVI update: Saskatchewan and Manitoba partner on liberation treatment
    Apr 08, 2011

    More evidence pregnancy is safe with MS
    Apr 08, 2011

    Warm or ever Hot weather - and how it can affect the MS patient
    Apr 08, 2011

    Pediatric MS: Self-Advocacy and the Healthcare Team
    Apr 08, 2011

    Cerebrospinal Venous Angioplasty Safe in MS as per the Society of Interventional Radiology
    Apr 06, 2011

    RSVP's needed for an MS education Program in Melbourne, Fl. - “New and Emerging Therapies Brings Quality of Life to those affected by Multiple Sclerosis”
    Apr 06, 2011


    Pharmaceutical Resources
    Avonex - MS ActiveSource
    (800) 456-2255
    Betaseron - Betaplus MS Support
    (800) 788-1467
    Copaxone - Shared Solutions
    (800) 887-8100
    Extavia - Patient Support
    (866) 925-2333
    Gilenya - Patient Support
    (877) 408-4974
    Rebif  - MS LifeLines
    (877) 447-3243  ---------------------
    Novantrone -
    (877) 447-3243
    Tysabri -TOUCH  Program
    (800) 456-2255   
     SOCIAL MEDIA and Other Learning Methods

    Find us on  Facebook at our  primary page: 


    For all affected by MS, Click:   

    For Caregivers, Click:  
    For the Patient with a progressive form of MSClick: 
    Find Stuart on Facebook:
    WATCH our archived Podcasts (webcasts)
    Visit our Online Charity Auctions regularly, and please bid. We always have a lot of wonderful things up for sale
    Maybe you will find something for yourself or, perhaps, a gift for someone else. 
    SEE Patient and MS learning Videos
    Scroll to the bottom of the blog-page to see all the videos found there, for you to learn from.
    Come back to see us next week and please tell others of our new easy to read look  
    Visit Our Blog, Bookmark the website and review each week's informational M.S. postings by Clicking here
    Facebook and Twitter 
    information and Website
    addresses (URL's)  
    TIME and Effort are put into each week's  e-newsletters and podcast series. 
    Please share the information we provide to educate and inform, with others. 

     Sponsorships for this e-Newsletter and our
    podcast series, are provided by:  
    OUR MISSION:  'MS Views and News' (MSVN)  is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis.  In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.

    -Newsletter Disclaimer:
    ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

    If you no longer wish to receive these emails, or you wish to update your profile, please click here.

    No comments:

    Post a Comment

    Leave comments only that directly pertain to each article.
    All solicitations will be removed.